ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,119 | +3.5% | 240 | +4.3% | 0.00% | – |
| Q2 2023 | $15,574 | +25.2% | 230 | 0.0% | 0.00% | – |
| Q1 2023 | $12,443 | -10.3% | 230 | -0.9% | 0.00% | – |
| Q4 2022 | $13,876 | +38.8% | 232 | +0.4% | 0.00% | – |
| Q3 2022 | $10,000 | -23.1% | 231 | +2.7% | 0.00% | – |
| Q2 2022 | $13,000 | -71.1% | 225 | -64.3% | 0.00% | -100.0% |
| Q1 2022 | $45,000 | +104.5% | 630 | +83.1% | 0.00% | – |
| Q4 2021 | $22,000 | +46.7% | 344 | +72.0% | 0.00% | – |
| Q3 2021 | $15,000 | -6.2% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $16,000 | -5.9% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $17,000 | +30.8% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | +8.3% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | -7.7% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -7.1% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $14,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |